Key result
Oral contraceptives are not considered typical atherogenic risk factors, and there is no evidence suggesting a difference among formulations in cardiovascular disease incidence.
Why the study?
Do oral contraceptives increase the risk of cardiovascular disease?
Population
Women using oral contraceptives
Design
Review
Authors
Loading...
Supports lack of atherogenic CVD risk with oral contraceptives; leaves open formulation-specific thrombosis mechanisms.
Do oral contraceptives increase the risk of cardiovascular disease?
Current evidence does not suggest a difference in cardiovascular disease incidence among different oral contraceptives, and associated coronary thrombosis may not be driven by typical atherogenic changes.
Jukka T. Salonen (1989) conducted a review in Cardiovascular disease. Oral contraceptives was evaluated on Cardiovascular disease. Oral contraceptives are not considered typical atherogenic risk factors, and there is no evidence suggesting a difference among formulations in cardiovascular disease incidence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: